Try our Advanced Search for more refined results

In Re: Accutane Products Liability

Track this case

Case Number:

8:04-md-02523

Court:

Nature of Suit:

Personal Inj. Prod. Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

James S. Moody, Jr

Firms

Companies

Sectors & Industries:

March 01, 2013
Roche Inches Closer To Escaping Accutane MDL

A Florida federal judge found Thursday that Hoffman-La Roche Inc. adequately warned a user of the acne treatment Accutane about the risk of bowel injury, leaving only one suit remaining in the multidistrict litigation over the drug.
February 15, 2013
Roche Escapes 40 Accutane MDL Suits Due To Lack Of Expert

Hoffman-La Roche Inc. on Thursday defeated 40 lawsuits over injuries allegedly caused by its acne treatment Accutane because of the plaintiffs' failure to find an expert witness, leaving only two cases remaining in multidistrict litigation in Florida over the drug.
January 11, 2013
Roche Wants 40 Accutane Suits Junked For Lack Of Experts

Hoffmann-La Roche Inc. on Thursday asked a Florida federal judge to toss 40 suits from multidistrict litigation alleging the pharmaceutical company's acne treatment Accutane causes irritable bowel disease because the plaintiffs have failed to find an expert witness to support their claims.
August 07, 2012
Barr Uses Mensing To Escape Generic Accutane Case

A federal judge in Florida on Monday wiped out claims from a man diagnosed with inflammatory bowel disease after taking a generic version of Accutane, a blow to multidistrict litigation involving Barr Laboratories Inc. and the latest case derailed by the U.S. Supreme Court's Pliva v. Mensing decision.
July 24, 2012
Roche's Accutane Warning Passes Muster In MDL

Hoffmann-La Roche Inc. adequately warned an Accutane user about the risk of developing inflammatory bowel disease while on the acne drug, a Florida federal judge overseeing multidistrict litigation ruled Tuesday, a decision that could affect much larger Accutane litigation in New Jersey.
July 10, 2012
Barr Seeks To Use Mensing As Shield In Accutane MDL

Barr Laboratories Inc. on Monday argued that failure-to-warn claims from a man diagnosed with inflammatory bowel disease after using generic Accutane are blocked by the U.S. Supreme Court's Pliva Inc. v. Mensing ruling, as it sought to escape multidistrict litigation over the acne drug.
August 12, 2009
Expert Testimony Excluded Again In Accutane MDL

For the second time in two years, a district judge has thrown out the testimony of the plaintiffs' expert witness in an ongoing products liability case over acne treatment Accutane.
October 16, 2007
Swiss Defendants Get Accutane Claims Dismissed

Claims continue to be stripped from the Accutane multidistrict litigation, with a judge on Monday dismissing Swiss defendants F. Hoffmann-La Roche Ltd. and Roche Holding Ltd. from the case.
September 21, 2007
Accutane Trial To Begin Monday, As Planned

In a state case in the multidistrict product liability litigation over Accutane, a judge on Friday denied defendant Hoffmann-La Roche’s motion for summary judgment, clearing the way for the trial to kick off on Monday.